Skip to main content
. 2025 Nov 6;16:1694640. doi: 10.3389/fneur.2025.1694640

Table 2.

Univariate and multivariate analyses for the potential prognostic factors according to the presence of HT.

Univariate analysis Multivariate analysis
P-value OR (95%CI) P-value
Demographic characteristics
Age (years) 0.004 1.02 (1.00–1.04) 0.096
Male 0.606 - -
BMI (Kg/m^2) 0.221 - -
Clinical characteristics
Smoking 0.767 - -
SBP (mmHg) 0.023 1.01 (1.00–1.02) 0.103
DBP (mmHg) 0.545 - -
NIHSS <0.001 1.03 (0.99–1.08) 0.130
ASPECTS <0.001 0.78 (0.67–0.92) 0.003
Antiplatelet aggregation 0.259 - -
Lipid-lowering 0.390 - -
Intravenous thrombolysis 0.142 - -
Medical history
Hypertension 0.235 - -
Diabetes 0.182 - -
History of stroke 0.169 - -
Coronary heart disease 0.203 - -
Laboratory characteristics
TC (mmol/L) 0.259 - -
TG (mmol/L) 0.179 - -
LDL-C (mmol/L) 0.094 - -
HDL-C (mmol/L) 0.125 - -
AIP 0.027 0.20 (0.07–0.53) 0.001
HbA1c (%) 0.056 - -
Homocysteine (μmol/L) 0.055 - -
Albumin (g/L) 0.022 0.97 (0.92–1.01) 0.164
Surgical characteristics
OPT (min) 0.556 - -
Surgery duration (min) 0.003 1.00 (1.00–1.01) 0.167
The number of endovascular treatments <0.001 1.52 (1.23–1.87) <0.001
Imaging characteristics
Infarct volume (ml) <0.001 1.00 (1.00–1.01) 0.036